| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |